Vanita Jayswal
Vanita Jayswal has a total of 4 co-authors. Here are the top co-authors by number of shared publications:
- Ayola R. Leitao
Internal Medicine, Saint James School of Medicine, Park Ridge, USA
1 shared publication Enkhmaa Luvsannyam
Surgery, Avalon University School of Medicine, Willemstad, CUW
1 shared publication- Frederick Tiesenga
General Surgery, West Suburban Medical Center, Chicago, USA
1 shared publication - Molly S. Jain
Medicine, Saint James School of Medicine, Park Ridge, USA
1 shared publication
Latest Publications
- Open Access
- 13 May 2022
- Published by Springer Nature in Cureus
- Vol. 14 (5) , e24973
Lupus Cerebritis as a Rare Neuropsychiatric Manifestation of Systemic Lupus Erythematosus
Mixed connective tissue disease (MCTD) is a rare autoimmune condition that shows an overlap of at least two connective tissue diseases (CTD) including systemic lupus erythematosus (SLE), rheumatoid arthritis (RA), scleroderma, Sjögren’s syndrome, polymyositis, or dermatomyositis. From a laboratory standpoint, MCTD is associated with high titers of anti-U1-RNP antibodies, which makes it difficult to determine whether it is a variant of each of the respective CTDs or a different entity altogether. Our objective is to report the case of a patient with MCTD presenting with status epilepticus who was ultimately diagnosed with lupus cerebritis. The case also highlights the development of complications unrelated to MCTD that made the management even more challenging. Overall, the authors emphasize the rareness of lupus cerebritis as a presentation, the diagnostic challenges faced due to the lack of classical manifestations of SLE, and how the complicated clinical course makes a downhill prognosis more likely.
- 13 May 2022
- Published by Springer Nature in Cureus
- Vol. 14 (5) , e24973
Open AccessLupus Cerebritis as a Rare Neuropsychiatric Manifestation of Systemic Lupus Erythematosus
Mixed connective tissue disease (MCTD) is a rare autoimmune condition that shows an overlap of at least two connective tissue diseases (CTD) including systemic lupus erythematosus (SLE), rheumatoid arthritis (RA), scleroderma, Sjögren’s syndrome, polymyositis, or dermatomyositis. From a laboratory standpoint, MCTD is associated with high titers of anti-U1-RNP antibodies, which makes it difficult to determine whether it is a variant of each of the respective CTDs or a different entity altogether. Our objective is to report the case of a patient with MCTD presenting with status epilepticus who was ultimately diagnosed with lupus cerebritis. The case also highlights the development of complications unrelated to MCTD that made the management even more challenging. Overall, the authors emphasize the rareness of lupus cerebritis as a presentation, the diagnostic challenges faced due to the lack of classical manifestations of SLE, and how the complicated clinical course makes a downhill prognosis more likely.